Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Phase II results reported for Neurobloc

Oct. 2, 1997

Dexketoprofen trometamol submitted for mutual EC recognition

Oct. 2, 1997

Optically active analgesic agent presented by Roche

Oct. 2, 1997

U.S. patent issued for Cell Genesys CNS gene therapy

Oct. 1, 1997

SNX-111 clinical data presented at international pain meeting

Oct. 1, 1997

Encouraging phase I results for porcine neural cell product

Oct. 1, 1997

Canadian regulatory review of modafinil continues

Sep. 30, 1997

SNX-111 study in head trauma resumed

Sep. 30, 1997

Seroquel cleared for marketing in U.S.

Sep. 30, 1997

Rhone-Poulenc Rorer discloses new AMPA/NMDA receptor antagonists

Sep. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...